Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China · Delayed Price · Currency is CNY 22.41
-0.39 (-1.71%)
Jul 21, 2026, 3:00 PM CST
SHA:600285 Market Cap
SHA:600285 has a market cap or net worth of 12.62 billion as of July 21, 2026. Its market cap has decreased by -1.84% in one year.
Market Cap
12.62B
Enterprise Value
11.74B
Revenue
3.96B
Ranking
n/a
PE Ratio
16.12
Stock Price
22.41
ChartMarket Cap Chart
Since January 2, 2001, SHA:600285's market cap has increased from 2.12B to 12.62B, an increase of 495.70%. That is a compound annual growth rate of 7.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 12.62B | 8.21% |
| Dec 31, 2025 | 11.66B | -6.54% |
| Dec 31, 2024 | 12.48B | 29.34% |
| Dec 29, 2023 | 9.65B | 31.14% |
| Dec 30, 2022 | 7.36B | -17.51% |
| Dec 31, 2021 | 8.92B | 85.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Kangtai Biological Products | 13.56B |
| Harbin Pharmaceutical Group | 13.42B |
| Zhejiang Hisun Pharmaceutical | 13.11B |
| Shenzhen Hepalink Pharmaceutical Group | 13.00B |
| Nanjing King-Friend Biochemical Pharmaceutical | 12.75B |
| Zhejiang Jiuzhou Pharmaceutical | 12.75B |
| Guobang Pharma | 12.52B |
| Shenzhen Chipscreen Biosciences | 12.38B |